Akero Shows FGF21/GLP-1 Combo’s Potential In NASH And Type 2 Diabetes

 
• By Joseph Haas
  
Type 2 diabetes
Akero combo shows safety, efficacy in NASH patients with type 2 diabetes • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D